Price (90d)
No price history yet — the daily price refresh runs once a day.
Signal Score (90d)
175Quote
Valuation & Ratios
Returns & Efficiency
Revenue & Net Income (Annual)
| Fiscal Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $3.02B | $72.06M | $0.23 |
| 2024 | $2.79B | $-116.89M | $-0.38 |
| 2023 | $2.39B | $-83.99M | $-0.48 |
| 2022 | $2.21B | $-129.99M | $-0.86 |
| 2021 | $2.09B | $10.62M | $0.07 |
Social Signal Score
Earnings
Thu, Oct 29(in 2 months)
Consensus estimate $0.26 per share
Typical surprise +34.8% (median, so one quarter with a near-zero estimate can't distort it)
- Thu, Jul 30$0.30 vs $0.22beat
- Thu, May 7$0.27 vs $0.17beat
- Fri, Feb 27$0.21 vs $0.18beat
- Thu, Oct 30$0.17 vs $0.13beat
- Tue, Aug 5$0.25 vs $0.18beat
- Fri, May 2$0.21 vs $0.15beat
Estimates and results for AMRX via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.
Valuation
Project earnings forward and see what return today's price implies.
Seeded from AMRX's reported EPS growth of 34.6% a year over 4 years. Historical EPS growth of 35% reflects a recovery from a low base and won't persist. Capped at 30% as a starting point.
- EPS in 5 years
- $0.85
- Implied price
- $46.96
- Return from $18.15
- 20.9% a year
To earn 15.0% a year on these assumptions you'd need to buy at $23.35 — today's price is already 22.3% below that.
How sensitive is that answer?
Annual return across nearby assumptions. If the result is only attractive in one corner, that is the finding.
| growth \ P/E | 39 | 47 | 55 | 63 | 71 |
|---|---|---|---|---|---|
| 20.0% | 4.2% | 8.2% | 11.6% | 14.7% | 17.5% |
| 25.0% | 8.6% | 12.7% | 16.3% | 19.5% | 22.4% |
| 30.0% | 12.9% | 17.2% | 20.9% | 24.3% | 27.3% |
| 35.0% | 17.2% | 21.7% | 25.6% | 29.0% | 32.2% |
| 40.0% | 21.6% | 26.2% | 30.2% | 33.8% | 37.1% |
This is arithmetic on assumptions you chose, not a forecast or a recommendation. It ignores dividends, buybacks, share issuance and debt, and it assumes a company still earning money in 5 years. Change any input and the answer changes a lot — that sensitivity is the honest result, not a flaw in the model.
Mentions (3)
- Newszacks.com·3d ago·Positive
Is AMRX Stock a Buy as Growth Improves but Execution Risks Persist? Amneal enters the second half of 2026 with higher guidance and a broader pipeline, but Rytary erosion and execution risks raise the stakes.
View source ↗ - Newszacks.com·3d ago·Positive
AMRX Stock Surges 44.8% in 3 Months: Can the Rally Keep Running Now? Amneal 44.8% rally faces a test as earnings, launches and pipeline progress contend with Rytary erosion and a higher historical valuation.
View source ↗ - Newszacks.com·4d ago·Positive
Amneal (AMRX) Is a Great Choice for 'Trend' Investors, Here's Why Amneal (AMRX) could be a great choice for investors looking to make a profit from fundamentally strong stocks that are currently on the move. It is one of the several stocks that made it through our "Recent Price Strength" screen.
View source ↗